Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $316.05 | $7.17 | 4,305.80% | 6,321.00x | 222.40x | 7.00x | 8.48x | 17.03x | $529.27M | 1.52% | $4.13B | 37.48 | $32.88B | 103.38 | ||
| CORT | CORCEPT THERAPEUTICS INC | $83.76 | $27.15 | 208.45% | 83.76x | 84.66x | 11.70x | 13.94x | 1.46x | $162.57M | 1.87% | $631.90M | 6.10 | $8.69B | 131.74 | ||
| NVO | NOVO NORDISK A S | $48.09 | $139.24 | -65.46% | 13.37x | 2.03x | 4.39x | 8.16x | 0.15x | $9.34B | 4.37% | $26.18B | 5.89 | $224.34B | 9.04 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $400.23 | $30.22 | 1,224.23% | 1,291.06x | 213.78x | 16.39x | 226.07x | 5.22x | $221.36M | 0.42% | $233.89M | 1.78 | $54.60B | 359.38 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.31 | $11.79 | -29.51% | 17.31x | 6.36x | 5.51x | 3.51x | 0.34x | -$23.64M | -5.09% | $133.17M | 2.38 | $476.11M | 7.08 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $43.19 | $15.00 | 187.96% | 88.14x | 43.28x | 5.40x | 6.11x | 1.32x | $101.73M | 3.15% | $535.38M | 7.17 | $3.11B | 58.02 | ||
| GMAB | GENMAB A | $32.38 | $106.43 | -69.58% | 13.82x | 1.80x | 5.83x | 3.62x | 0.13x | $1.19B | 5.74% | $5.75B | 8.96 | $19.17B | 9.58 | ||
| ARGX | ARGENX SE | $854.99 | $283.62 | 201.46% | 34.17x | 47.73x | 27,580.32x | 7.28x | 2.30x | $467.72M | 0.90% | $7.17B | 117.50 | $49.78B | 61.36 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $200.33 | $66.11 | 203.04% | 86.72x | 26.86x | 15.61x | 4.15x | 1.41x | $30.76M | 0.78% | $950.17M | 48.53 | $4.25B | 41.30 | ||
| VCEL | VERICEL CORP | $36.05 | $6.70 | 438.07% | 138.65x | 131.52x | 7.04x | 5.66x | 2.58x | $20.38M | 1.12% | $321.86M | 6.38 | $1.82B | 62.12 | ||
| TECH | BIO-TECHNE CORP | $58.27 | $16.48 | 253.63% | 116.54x | 28.82x | 7.45x | 4.62x | 1.59x | $224.06M | 2.47% | $1.97B | 12.65 | $9.33B | 42.23 | ||
| RPRX | ROYALTY PHARMA PLC | $38.60 | $42.71 | -9.63% | 21.93x | 8.03x | 7.09x | 2.32x | 0.44x | $2.11B | 12.67% | $9.62B | 22.28 | $30.29B | 29.01 | ||
| KRYS | KRYSTAL BIOTECH INC | $240.80 | $68.29 | 252.64% | 34.90x | 38.54x | 18.68x | 6.14x | 3.17x | $166.02M | 2.38% | $1.14B | 39.30 | $6.60B | 34.14 | ||
| VCYT | VERACYTE INC | $42.92 | $9.33 | 360.01% | 110.05x | 80.92x | 6.82x | 2.70x | 2.25x | $98.21M | 2.91% | $1.26B | 15.98 | $3.12B | 54.67 | ||
| CRMD | CORMEDIX INC | $12.02 | $13.37 | -10.09% | 5.30x | 4.81x | 4.26x | 2.53x | 26.35x | $74.42M | 8.15% | $374.13M | 4.93 | $1.05B | 9.33 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.73 | $1.31 | 31.74% | 24.71x | 68.38x | 2.22x | 2.63x | 0.71x | -$11.69M | -8.50% | $52.91M | 0.67 | $133.66M | 15.07 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.13 | $0.76 | 837.35% | 101.86x | 46.60x | 6.04x | 6.74x | 7.48x | $3.05M | 0.48% | $101.92M | 1.12 | $647.62M | 48.95 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $16.18 | $8.27 | 95.75% | 27.90x | 20.60x | 8.02x | 5.83x | 1.23x | $119.87M | 5.62% | $365.77M | 2.78 | $2.14B | 20.66 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.15 | $43.31 | 41.19% | 22.48x | 20.39x | 3.80x | 1.94x | 0.82x | $832.13M | 7.09% | $6.06B | 31.54 | $11.09B | 14.36 | ||
| HALO | HALOZYME THERAPEUTICS INC | $67.35 | $76.00 | -11.38% | 13.77x | 10.52x | 6.35x | 15.72x | 0.53x | $602.40M | 7.63% | $503.92M | 4.30 | $9.01B | 10.66 | ||
| EXEL | EXELIXIS INC | $44.30 | $30.17 | 46.84% | 18.01x | 16.52x | 5.20x | 5.50x | 1.04x | $779.77M | 6.56% | $2.16B | 8.05 | $11.68B | 12.59 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $456.20 | $171.74 | 165.63% | 31.88x | 24.41x | 9.95x | 6.68x | 1.91x | $3.34B | 2.86% | $17.32B | 67.76 | $112.64B | 24.16 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.81 | $37.17 | 1.73% | 11.71x | 11.60x | 2.63x | 2.61x | 0.76x | $296.89M | 13.64% | $835.12M | 14.51 | $1.70B | 6.30 | ||
| ADMA | ADMA BIOLOGICS INC | $19.58 | $8.53 | 129.60% | 22.25x | 32.81x | 9.56x | 10.81x | 2.13x | $40.73M | 0.87% | $431.19M | 1.81 | $4.67B | 27.14 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.52 | $3.35 | 94.63% | 24.15x | 35.13x | 4.17x | 7.36x | 1.36x | $21.15M | 4.06% | $70.68M | 0.89 | $459.10M | 20.23 | ||
| MNKD | MANNKIND CORP | $5.84 | $1.45 | 303.51% | 58.40x | 73.37x | 5.71x | -40.25x | 2.50x | $43.39M | 2.41% | -$44.55M | -0.15 | $2.03B | 27.68 | ||
| INCY | INCYTE CORP | $102.69 | $68.68 | 49.53% | 17.00x | 14.71x | 4.17x | 4.33x | 1.13x | $1.20B | 5.96% | $4.65B | 23.77 | $17.74B | 10.54 | ||
| INVA | INNOVIVA INC | $19.99 | $15.51 | 28.91% | 10.58x | 9.33x | 3.55x | 1.48x | 1.64x | $196.54M | 14.24% | $1.01B | 14.63 | $1.28B | 5.94 | ||
| UTHR | UNITED THERAPEUTICS CORP | $517.13 | $201.73 | 156.35% | 18.16x | 18.73x | 7.24x | 3.38x | 5.31x | $1.12B | 4.95% | $6.59B | 150.46 | $20.93B | 11.80 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.74 | $12.35 | 92.27% | 13.26x | 14.75x | 5.03x | 3.17x | 4.54x | $234.54M | 8.06% | $920.25M | 7.51 | $2.23B | 6.89 | ||
| MDXG | MIMEDX GROUP INC | $7.05 | $2.80 | 151.99% | 25.18x | 16.46x | 2.65x | 4.37x | 2.24x | $66.82M | 6.40% | $238.95M | 1.61 | $920.25M | 13.30 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $767.96 | $372.93 | 105.93% | 17.67x | 17.49x | 5.58x | 2.61x | 2.37x | $4.22B | 5.31% | $30.96B | 298.82 | $80.91B | 14.16 | ||
| XOMA | XOMA ROYALTY CORP | $25.39 | $4.83 | 425.48% | 31.35x | 22.84x | 6.54x | 3.58x | 77.43x | -$12.41M | -4.03% | $87.94M | 7.25 | $355.84M | 13.30 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.